Prophylactic intratracheal polymyxin B/surfactant prevents bacterial growth in neonatal escherichia coli pneumonia of rabbits

Pediatric Research

Volumn 67, Issue 4, 2010, Pages 369-374

  Stichtenoth, Guido ^a   Linderholm, Bim ^a   Björkman, Marie Hägerstrand ^a   Walter, Gabi ^b   Curstedt, Tore ^a   Herting, Egbert ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; POLYMYXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; ESCHERICHIA COLI PNEUMONIA; EXPERIMENTAL RABBIT; LUNG COMPLIANCE; LUNG FUNCTION; NEWBORN; NONHUMAN; PLETHYSMOGRAPH; PRIORITY JOURNAL; PROPHYLAXIS; TIDAL VOLUME;

ANIMALS; ANIMALS, NEWBORN; ESCHERICHIA COLI; PNEUMONIA, BACTERIAL; POLYMYXIN B; PULMONARY SURFACTANTS; RABBITS; TRACHEA;

EID: 77949545946     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181d026f6     Document Type: Article

References (37)

1. Sarkar S, DeSantis ER, Kuper J 2007 Resurgence of colistin use. Nephrotoxic, neurotoxic effects of polymyxins. Am J Health Syst Pharm 64:2462-2466
2. Falagas ME, Kasiakou SK 2006 Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27
3. Robertson B, Schürch S 1998 Assessment of surfactant function. In: Uhlig S, Taylor AE (eds) Methods in Pulmonary Research. Birkäuser Verlag, Basel, Switzerland, pp 349-383
4. Taeusch HW, Keough KM 2001 Inactivation of pulmonary surfactant and the treatment of acute lung injuries. Pediatr Pathol Mol Med 20:519-536
5. Taut FJ, Rippin G, Schenk P, Findlay G, Wurst W, Häfner D, Lewis JF, Seeger W, Günther A, Spragg RG 2008 A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 134:724-732
6. Stichtenoth G, Jung P, Johansson J, Robertson B, Curstedt T, Herting E 2006 Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactiva-tion by meconium and reduce growth of Gram-negative bacteria in vitro. Pediatr Res 59:407-411
7. Sun B, Kobayashi T, Cursted T, Grossmann G, Robertson B 1991 Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur Respir J 4:364-370
8. Stichtenoth G, Linderholm B, Almlén A, Björkman MH, Byman I, Nordling K, Robertson B, Johansson J, Herting E, Curstedt T 2009 Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits. Crit Care Med 37:1750-1756
9. Johansson J, Some M, Linderholm BM, Almlén A, Curstedt T, Robertson B 2003 A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. J Appl Physiol 95:2055-2063
10. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E 2005 National Institute of Child Health and Human Development: very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network 2002-2003. Pediatr Infect Dis J 24:635-639
11. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347:240-247
12. Schrag SJ, Stoll BJ 2006 Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 25:939-940
13. Falagas ME, Kasiakou SK 2005 Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40:1333-1341
14. Evans ME, Feola DJ, Rapp RP 1999 Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria. Ann Pharmacother 33:960-967
15. van't Veen A, Mouton JW, Gommers D, Lachmann B 1996 Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol 119:1145-1148
16. van 't Veen A, Gommers D, Mouton JW, Kluytmans JA, Krijt EJ, Lachmann B 1996 Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity. Br J Pharmacol 118:593-598
17. Cajal Y, Ghanta J, Easwaran K, Surolia A, Jain MK 1996 Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts. Biochemistry 35:5684-5695
18. Zaltash S, Palmblad M, Curstedt T, Johansson J, Persson B 2000 Pulmonary surfactant protein B a structural model and a functional analogue. Biochim Biophys Acta 1466:179-186
19. Omri A, Suntres ZE, Shek PN 2002 Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64:1407-1413
20. Calkovska A, Some M, Linderholm B, Johansson J, Curstedt T, Robertson B 2005 Biophysical and physiological properties of porcine surfactant enriched with poly-myxin B. Biol Neonate 88:101-108
21. Flieger A, Gongab S, Faigle M, Mayer HA, Kehrer U, Mussotter J, Bartmann P, Neumeister B 2000 Phospholipase A secreted by Legionella pneumophila destroys alveolar surfactant phospholipids. FEMS Microbiol Lett 188:129-133
22. Wheeldon EB, Walker ME, Murphy DJ, Turner CR 1992 Intratracheal aerosoliza-tion of endotoxin in the rat: a model of the adult respiratory distress syndrome (ARDS). Lab Anim 26:29-37
23. van Helden HP, Kuijpers WC, Steenvoorden D, Go C, Bruijnzeel PL, van Eijk M, Haagsman HP 1997 Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res 23:297-316
24. Fox-Dewhurst R, Alberts MK, Kajikawa O, Caldwell E, Johnson MC II, Skerrett SJ, Goodman RB, Ruzinski JT, Wong VA, Chi EY, Martin TR 1997 Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am J Respir Crit Care Med 155:2030-2040
25. Tremblay LN, Slutsky AS 1998 Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 110:482-488
26. Uhlig S, Frerichs I 2008 Lung protective ventilation-pathophysiology and diagnostics. Anasthesiol Intensivmed Notfallmed Schmerzther 43:438-445
27. van Kaam AH, Lutter R, Lachmann RA, Haitsma JJ, Herting E, Snoek M, De Jaegere A, Kok JH, Lachmann B 2005 Effect of ventilation strategy and surfactant on inflammation in experimental pneumonia. Eur Respir J 26:112-117
28. Lachmann RA, van Kaam AH, Haitsma JJ, Lachmann B 2007 High positive end-expiratory pressure levels promote bacterial translocation in experimental pneumonia. Intensive Care Med 33:1800-1804
29. Danner RL, Joiner KA, Rubin M, Patterson WH, Johnson N, Ayers KM, Parrillo JE 1989 Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 33:1428-1434
30. Manocha S, Feinstein D, Kumar A, Kumar A 2002 Novel therapies for sepsis: antiendotoxin therapies. Expert Opin Investig Drugs 11:1795-1812
31. van Rozendaal BA, van de Lest CH, van Eijk M, van Golde LM, Voorhout WF, van Helden HP, Haagsman HP 1999 Aerosolized endotoxin is immediately bound by pulmonary surfactant protein D in vivo. Biochim Biophys Acta 1454:261-269
32. Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA 2006 Intratracheal recombinant surfactant protein D prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 173:1342-1347
33. Stamme C, Wright JR 1999 Surfactant protein A enhances the binding and deacy-lation of E. coli LPS by alveolar macrophages. Am J Physiol 276:L540-L547
34. van Helden HP, Kuijpers WC, Langerwerf PE, Langen RC, Haagsman HP, Bruijn-zeel PL 1998 Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur Respir J 12:533-539
35. Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP 1992 Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7:257-260
36. Thomassen MJ, Antal JM, Barna BP, Divis LT, Meeker DP, Wiedemann HP 1996 Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. Am J Physiol 270:L159-L163
37. Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B 1994 Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 36:784-791